Showing results (3071-3080 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|November 5, 2018
Small, Prospective, Observational, Pilot Study in Patients with Severe Asthma after Discontinuation of Omalizumab TreatmentIrena Krčmová, Jakub Novosad, Eva Malá, et al.
Clinical Therapeutics|November 7, 2018
Colchicine in Stable Coronary Artery DiseaseAernoud T L Fiolet, Stefan M Nidorf, Arend Mosterd, et al.
Clinical Therapeutics|November 21, 2018
Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted StateKevin C Maki, Orsolya M Palacios, Mary A Buggia, et al.
Clinical Therapeutics|November 22, 2018
Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy VolunteersOfir Moreno, Todd Butler, Vanessa Zann, et al.
Clinical Therapeutics|November 22, 2018
The Role of Double and Triple Therapy with Direct Oral Anticoagulants in Coronary Artery Disease, Peripheral Artery Disease, and StrokeNatasha Romero, Kenneth Lupi, Danielle Carter, et al.
Clinical Therapeutics|November 22, 2018
On the Policy of the Italian Government in the Discovery, Development, and Access to MedicinesCristina Scavone, Carla Carnovale, Rosanna Ruggiero, et al.
Clinical Therapeutics|February 18, 2017
Cost-utility of First-line Disease-modifying Treatments for Relapsing-Remitting Multiple SclerosisErkki Soini, Jaana Joutseno, Marja-Liisa Sumelahti
Clinical Therapeutics|February 27, 2017
Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel SyndromeSunil Kumar, Ratnakar Shukla, Prabhat Ranjan, et al.
Clinical Therapeutics|February 27, 2017
The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment OutcomesVictor Chavarria, João Vian, Círia Pereira, et al.
Clinical Therapeutics|April 2, 2017
In Vitro Anaerobic Pharmacokinetic/Pharmacodynamic Model to Simulate the Bactericidal Activity of Levornidazole Against Bacteroides fragilisJiali Hu, Jing Zhang, Yuancheng Chen, et al.
Pageof 680